Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Pediatric Urolithiasis After ESWL
NCT05759767Unknown
- Sponsor
- Mansoura University
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tamsulosin in urolithiasis, sponsored by Mansoura University. Primary endpoint: Stone-free rate at 3 months. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT05759767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05759767.